PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 124 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $148,096 | -91.9% | 32,265 | -94.2% | 0.00% | -100.0% |
| Q4 2021 | $1,823,000 | -1.3% | 557,538 | +120.3% | 0.00% | 0.0% |
| Q3 2021 | $1,847,000 | -28.3% | 253,063 | -3.9% | 0.00% | 0.0% |
| Q2 2021 | $2,575,000 | +108.7% | 263,292 | +101.3% | 0.00% | 0.0% |
| Q1 2021 | $1,234,000 | -44.3% | 130,791 | -32.1% | 0.00% | 0.0% |
| Q4 2020 | $2,217,000 | -17.5% | 192,581 | -26.8% | 0.00% | -50.0% |
| Q3 2020 | $2,687,000 | -7.9% | 262,969 | -7.8% | 0.00% | -33.3% |
| Q2 2020 | $2,919,000 | +108.1% | 285,066 | +49.4% | 0.00% | +50.0% |
| Q1 2020 | $1,403,000 | +630.7% | 190,838 | +771.1% | 0.00% | – |
| Q4 2019 | $192,000 | +28.0% | 21,907 | +57.3% | 0.00% | – |
| Q3 2019 | $150,000 | +354.5% | 13,926 | +435.2% | 0.00% | – |
| Q2 2019 | $33,000 | +120.0% | 2,602 | +577.6% | 0.00% | – |
| Q1 2019 | $15,000 | +87.5% | 384 | -6.8% | 0.00% | – |
| Q4 2018 | $8,000 | -11.1% | 412 | +105.0% | 0.00% | – |
| Q3 2018 | $9,000 | -90.5% | 201 | -87.5% | 0.00% | – |
| Q2 2018 | $95,000 | +1.1% | 1,609 | +16.4% | 0.00% | – |
| Q1 2018 | $94,000 | -95.6% | 1,382 | -93.6% | 0.00% | -100.0% |
| Q4 2017 | $2,135,000 | -81.1% | 21,596 | -77.1% | 0.00% | -80.0% |
| Q3 2017 | $11,286,000 | +2311.5% | 94,246 | +1661.3% | 0.01% | – |
| Q2 2017 | $468,000 | +140.0% | 5,351 | +1.8% | 0.00% | – |
| Q1 2017 | $195,000 | +1200.0% | 5,254 | +2594.4% | 0.00% | – |
| Q4 2015 | $15,000 | +1400.0% | 195 | +1850.0% | 0.00% | – |
| Q3 2015 | $1,000 | -99.8% | 10 | -99.8% | 0.00% | -100.0% |
| Q2 2015 | $510,000 | +25400.0% | 4,369 | +54512.5% | 0.00% | – |
| Q1 2015 | $2,000 | -99.4% | 8 | -99.5% | 0.00% | – |
| Q4 2014 | $325,000 | -77.9% | 1,718 | -72.1% | 0.00% | -100.0% |
| Q3 2014 | $1,469,000 | +3572.5% | 6,155 | +925.8% | 0.00% | – |
| Q2 2014 | $40,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |